InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Ruth Matthew R., Directeur Commercial. Director active across 1 company, notably Opiant Pharmaceuticals, INC.. In total, 9 reports have been recorded. Split: 2 buys · 1 sell. Total volume traded: €70k. Activity tracked since 19 July 2021. The latest transaction was disclosed on 2 March 2023 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
19,250 shares@ US$20.0083.7% of flowCommon StockSEC:0001385508-23-000073:0
1,084 shares@ US$10.622.6% of flowCommon StockSEC:0001385508-22-000114:0
2,000 shares0Common StockSEC:0001385508-22-000099:0
12,000 shares0Common StockSEC:0001385508-22-000009
12,000 shares0Common StockSEC:0001385508-22-000009:0
2,000 shares@ US$17.346.8% of flowCommon StockSEC:0001385508-21-000121
Ideal exit: 28 May 2022 (T+270)
2,000 shares@ US$17.3450.0% of flowCommon StockSEC:0001385508-21-000121:0
Ideal exit: 28 May 2022 (T+270)
15,000 shares0Common StockSEC:0001385508-21-000096
15,000 shares0Common StockSEC:0001385508-21-000096:0
9 of 9 declarations
About Ruth Matthew R.
Matthew R. Ruth is the Chief Commercial Officer at OPIANT PHARMACEUTICALS, INC. In this role, he is responsible for the company's commercial strategy and business development. His expertise in the pharmaceutical sector is essential to support OPIANT's growth. Matthew R. Ruth collaborates with his team to develop initiatives that promote product innovation and expansion.
